This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Kolon Life Science, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Eunjin Lee: Innovator in Cancer Treatment
Introduction
Eunjin Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Eunjin Lee holds a patent for a recombinant vaccinia virus, which is designed to selectively kill cancer cells while minimizing toxicity to normal cells. This invention demonstrates excellent reproducibility in cancer cells and offers a promising approach for treating cancer safely in humans.
Career Highlights
Throughout her career, Eunjin Lee has worked with notable companies, including Kolon Life Science, Inc. and Vitesco Technologies GmbH. Her experience in these organizations has contributed to her expertise in developing advanced medical technologies.
Collaborations
Eunjin Lee has collaborated with talented individuals such as Sujeong Kim and Minjung Kim, enhancing her research efforts and broadening the impact of her work.
Conclusion
Eunjin Lee's innovative work in developing a recombinant vaccinia virus showcases her commitment to advancing cancer treatment. Her contributions are paving the way for safer and more effective therapies in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile